Medigen Biotechnology Corp.

  • About us
    • About us
    • History
    • Corporate milestones
    • Leadership
  • R&D
    • Clinical trials
    • R&D achievements
    • Collaborations
    • Subsidiaries
  • News
    • Press releases
    • Events
  • ESG
  • Investors
    • Corporate governance
    • Financials
    • Shareholder services
    • Material information
    • FAQs
  • Careers
    • Join us
    • Learning and development
    • Compensation and benefit
    • Sustainable talents
  • Contact
  • 繁體中文
  • 簡體中文
  • English

Press Releases

  • 2017/08/07 Enrollment of first patient in melanoma phase II clinical trial for Telomelysin® (OBP-301) in the US MORE
  • 2017/03/13 TBG Biotechnology and Medigen Collaborate with National Taiwan University to Develop Genetic Test for Adverse Drug Reactions MORE
  • 2017/01/03 The First EV71 Vaccine Protecting 2 ~ 6 Months Old Babies Wins Taiwan's National Innovation Award MORE
  • 2016/12/29 Medigen will conduct melanoma and esophageal cancer clinical trials with Oncolys MORE
  • 2016/12/09 TBG Diagnostics and Omixon formalise Asia Pacific partnership for Holotype HLA Typing product distribution MORE
  • 2016/12/09 MVC Obtains US NIH's Authorization to Develop Dengue Vaccine in 17 Countries MORE
  • 2016/12/05 Winston's Cosmetic Factory Pass ISO22716:2007 MORE
  • 2016/12/05 Winston is helping to result Vitamin A Eye ointment shortage MORE
  • 2016/12/05 Medigen's Liver Cancer New Drug OBP-301 has signed License Agreement with Jiangsu Hengrui Medicine MORE
  • 2016/11/23 Medigen Vaccine Biologics (MVC)'s Inaugurates Taiwan's First Cell-Based Vaccine Manufacturing Plant MORE
  • 1
  • 2
  • 3
  • 4
  • 5

About us

  • About us
  • History
  • Corporate milestones
  • Leadership

R&D

  • Clinical trials
  • R&D achievements
  • Collaborations
  • Subsidiaries

News

  • Press releases
  • Events

ESG

Investors

  • Corporate governance
  • Financials
  • Shareholder services
  • Material information
  • FAQs

Careers

  • Join us
  • Learning and development
  • Compensation and benefit
  • Sustainable talents

Contact

  • Privacy Policy
  • Cookie Policy
Copyright © 2025 Medigen Biotechnology Corp. All Rights Reserved.